Patrys

Patrys EBIT

The EBIT of Patrys (PAB.AX) as of Nov 16, 2026 is -3.42 M AUD. In the previous year, EBIT was -2.71 M AUD — a change of 26.35% (lower).

EBIT

-3.42 MAUD

YoY

26.35%

Last updated:

In 2026, Patrys's EBIT was -3.42 M AUD, a 26.35% increase from the -2.71 M AUD EBIT recorded in the previous year.

The Patrys EBIT history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT
Date
EBIT
Jan 1, 2019
-3.41 M AUD
Jan 1, 2020
-3.49 M AUD
Jan 1, 2021
-5.86 M AUD
Jan 1, 2022
-11.37 M AUD
Jan 1, 2023
-9.86 M AUD
Jan 1, 2024
-3.54 M AUD
Jan 1, 2025
-2.71 M AUD
Jan 1, 2026
-3.42 M AUD
The Patrys EBIT history
YEAREBITYoY
-3.42 MAUD+26.35%
-2.71 MAUD-23.44%
-3.54 MAUD-64.11%
-9.86 MAUD-13.31%
-11.37 MAUD+94.16%
-5.86 MAUD+67.68%
-3.49 MAUD+2.42%
-3.41 MAUD+36.60%
-2.50 MAUD+5.82%
-2.36 MAUD+37.04%
-1.72 MAUD-50.57%
-3.48 MAUD-52.15%
-7.28 MAUD+36.28%
-5.34 MAUD-32.78%
-7.95 MAUD-14.09%
-9.25 MAUD-8.58%
-10.12 MAUD-14.96%
-11.90 MAUD+37.26%
-8.67 MAUD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Patrys Revenue

Patrys Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2019
844,365.00 AUD
-3.41 M AUD
-411,326.00 AUD
Jan 1, 2020
27,500.00 AUD
-3.49 M AUD
-2.75 M AUD
Jan 1, 2021
27,500.00 AUD
-5.86 M AUD
-4.06 M AUD
Jan 1, 2022
27,500.00 AUD
-11.37 M AUD
-6.78 M AUD
Jan 1, 2023
2.85 M AUD
-9.86 M AUD
-7.06 M AUD
Jan 1, 2024
1.39 M AUD
-3.54 M AUD
-3.54 M AUD
Jan 1, 2025
828,540.00 AUD
-2.71 M AUD
-3.01 M AUD
Jan 1, 2026
8,985.00 AUD
-3.42 M AUD
-3.41 M AUD

Patrys Margins

Patrys stock margins

The Patrys margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Patrys. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Patrys.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2019
100.00 %
-404.01 %
-48.71 %
Jan 1, 2020
2,810.34 %
-12,705.02 %
-9,994.69 %
Jan 1, 2021
4,866.83 %
-21,303.78 %
-14,774.26 %
Jan 1, 2022
12,122.10 %
-41,362.58 %
-24,655.87 %
Jan 1, 2023
98.35 %
-345.77 %
-247.61 %
Jan 1, 2024
100.00 %
-253.85 %
-253.85 %
Jan 1, 2025
100.00 %
-327.03 %
-363.69 %
Jan 1, 2026
100.00 %
-38,103.23 %
-38,003.23 %

Patrys Stock analysis

What does Patrys do? The company Patrys Ltd is a biotechnology company based in Perth, Australia. It was founded in 2001 by a team of scientists and investors with the aim of developing and marketing targeted cancer treatments. Patrys focuses on the development of monoclonal antibodies and peptides containing therapeutic agents for cancer treatment. The main business model of Patrys is to develop and market new treatment options for cancer patients. The company utilizes the latest advancements in cancer research to develop innovative therapies tailored to the specific characteristics of each type of cancer. Patrys collaborates with leading scientists, research organizations, and pharmaceutical companies to develop a comprehensive portfolio of cancer treatments. Patrys has different business areas, all focused on the development of cancer treatments. One of these areas is the field of monoclonal antibodies, where Patrys concentrates on developing antibodies that can recognize and target specific proteins in cancer tissue. Another area focuses on the development of peptides specifically tailored to cancer cells. Patrys' products cover a variety of cancer types, including lung cancer, breast cancer, prostate cancer, colorectal cancer, and leukemia. The company's leading product is currently the antibody therapeutic PAT-LM1, used for the treatment of lung cancer. PAT-LM1 is a monoclonal antibody that targets a specific protein in the tumor, effectively combating the disease. The drug is currently in phase II clinical trials and showing promising results. Patrys is a company operating in a growing market. The global demand for cancer treatments is increasing, and Patrys has established itself as a significant player in this field. The company has gained recognition in recent years for its innovative therapy approaches and strong research and development team. Patrys aims to provide cancer patients with real hope for a cure and improve their quality of life. Overall, Patrys is a company operating in a rapidly growing market with a promising future. The company has developed a wide range of cancer treatments and works closely with leading experts and pharmaceutical companies to strengthen its position as an innovative and relevant player in cancer research. Patrys has a clear vision that it pursues, presenting an opportunity to play a significant role in the near future in a rapidly growing and highly relevant market. Patrys is one of the most popular companies on Eulerpool.

EBIT Details

Analyzing Patrys's EBIT

Patrys's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.

Year-to-Year Comparison

A yearly comparison of Patrys's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.

Impact on Investments

Patrys's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.

Interpreting EBIT Fluctuations

Fluctuations in Patrys’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.

Frequently Asked Questions about Patrys stock

EBIT of Patrys is -3.42 M AUD in 2026.

EBIT of Patrys changed from -2.71 M AUD to -3.42 M AUD, representing a 26.35% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBIT Patrys since 2006 – with annual values, charts, and detailed analysis.

"Earnings before interest and taxes", abbreviated as EBIT, is also referred to as the operating result of a company. It is a key figure that allows the profit to be assessed over a specific period of time, usually a fiscal year. Taxes and interest are not deducted from EBIT, making it suitable for international comparisons of different companies.

Net income
+ Tax expense
+ Interest expense and other financial expenses
- Interest income and other financial income
= EBIT (operating profit)

EBIT's AUD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBIT's Patrys historically and in real time.

The sales revenue is important for evaluating a stock.

EBIT is an acronym for "Earnings Before Interest and Tax" and represents a company's gross profit before taxes and interest are deducted. The EBIT amount is often used as a metric to evaluate a company.

History

The EBIT was originally introduced in the 1940s when the US Internal Revenue Service (IRS) passed a new tax law. This law required companies to calculate their profit before deducting taxes and interest on loans (or "interest and taxes"). Since then, the EBIT has been used as one of the key financial indicators in evaluating a company.

Usage

The EBIT can be used to assess a company by comparing its financial results to a benchmark or a comparative value. The EBIT is also used to determine how much the company's shareholders will receive from its operating income.

Calculation

EBIT is calculated by deducting taxes and interest on loans from the company's net profit. This amount can be calculated in various ways, but the most common method is as follows:

EBIT = Net profit + interest and taxes

Example: Eulerpool: Your source for quantitative stock data At Eulerpool, we are dedicated to providing you with comprehensive and accurate stock information. Our website offers a wide range of tools and features, including charts, stock lists, and more. Whether you are an experienced investor or just starting out, our platform is designed to meet your needs. With our in-depth analytics and algorithms, you can make informed decisions and stay ahead of the market. Explore our extensive collection of stocks, track their performance, and access real-time data. With Eulerpool, you can easily navigate the world of finance and monitor the stocks that matter to you. Join our community today and gain valuable insights into the world of stocks and investments. Sign up for free and discover the power of Eulerpool. Stay informed. Stay ahead. Eulerpool - your trusted partner in stock data.
Net profit of XYZ Co. = $1,000,000
Interest and taxes = $ 500,000
EBIT of XYZ Co. = $1,500,000

Application

The EBIT value is often used to determine and evaluate the financial stability of a company. The EBIT value can also be used to determine how much money a company can spend on investments or dividends.

Use of EBIT in stock investment

Investors use EBIT to determine if a stock is over- or undervalued. If a company has a high EBIT value, it may indicate that its stock is overvalued, as the profit it generates could be lower than what it would generate with a different stock.

Advantages of EBIT

EBIT is a helpful measure for determining the financial stability of a company. There are several advantages associated with using EBIT, such as:
- EBIT eliminates the impact of financing on the company's earnings.
- It is a useful measure for determining the profits that a company can distribute to its shareholders.
- It can be used to determine whether a stock is overvalued or undervalued.

Disadvantages of EBIT

There are also some disadvantages to using EBIT, such as:
- EBIT cannot be used as the sole measure to evaluate a company as it does not reflect the overall profit of the company.
- EBIT can be influenced by unforeseen events such as a tax increase.
- EBIT is not always a reliable indicator of a company's future profit development.

Conclusion

The EBIT is an important measure used to evaluate a company. It can be used to determine how much money a company can generate from its operational results and whether a stock is overvalued or undervalued. However, the EBIT also has some disadvantages as it does not reflect the overall profitability of a company and can be influenced by unforeseen events. Therefore, it is important to consider the EBIT in conjunction with other financial indicators to obtain a complete picture of the company.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Patrys

All Key Metrics — Patrys